blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3744345

EP3744345 - ANTIBODY FORMULATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.12.2022
Database last updated on 22.08.2024
FormerThe patent has been granted
Status updated on  07.01.2022
FormerGrant of patent is intended
Status updated on  25.08.2021
FormerRequest for examination was made
Status updated on  28.05.2021
FormerThe application has been published
Status updated on  30.10.2020
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024  [2024/29]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2020/49]
Inventor(s)01 / GOKARN, Yatin
15 Hilltop Avenue
Lexington, MA 02421 / US
02 / ZARRAGA, Isidro, E.
Genentech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
03 / ZARZAR, Jonathan
Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
04 / PATAPOFF, Thomas
Genentech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
05 / WURTH, Christine
F. Hoffmann-la Roche AG
Grenzacherstrasse 124
4070 Basel / CH
 [2020/50]
Former [2020/49]01 / GOKARN, Yatin
Genentech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
02 / ZARRAGA, Isidro, E.
Genentech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
03 / ZARZAR, Jonathan
Genetech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
04 / PATAPOFF, Thomas
Genentech Inc.
1 DNA Way
South San Francisco, CA 94080 / US
05 / WURTH, Christine
F. Hoffmann-la Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2022/06]
Former [2020/49]Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
Application number, filing date20181968.713.03.2014
[2020/49]
Priority number, dateUS201361780899P13.03.2013         Original published format: US 201361780899 P
[2020/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3744345
Date:02.12.2020
Language:EN
[2020/49]
Type: B1 Patent specification 
No.:EP3744345
Date:09.02.2022
Language:EN
[2022/06]
Search report(s)(Supplementary) European search report - dispatched on:EP25.09.2020
ClassificationIPC:A61K39/395, A61K47/26, A61K9/08, C07K16/22, C07K16/28
[2020/49]
CPC:
A61K47/26 (EP,IL,KR,RU,US); A61K39/395 (EP,IL,KR,RU); A61K39/39591 (EP,IL,KR,US);
A61K47/02 (KR); A61K47/183 (KR); A61K9/08 (EP,IL,KR,US);
A61P35/00 (EP,IL,RU); A61P35/02 (EP,IL); A61P9/00 (EP,IL);
C07K16/22 (EP,IL,KR,US); C07K16/2887 (EP,IL,KR,US); C07K2317/24 (KR);
C07K2317/54 (KR); C07K2317/55 (KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/26]
Former [2020/49]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ANTIKÖRPERFORMULIERUNGEN[2020/49]
English:ANTIBODY FORMULATIONS[2020/49]
French:FORMULATIONS D'ANTICORPS[2020/49]
Examination procedure20.05.2021Amendment by applicant (claims and/or description)
20.05.2021Examination requested  [2021/26]
20.05.2021Date on which the examining division has become responsible
26.08.2021Communication of intention to grant the patent
22.12.2021Fee for grant paid
22.12.2021Fee for publishing/printing paid
22.12.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14772646.7  / EP2968553
Opposition(s)10.11.2022No opposition filed within time limit [2023/03]
Fees paidRenewal fee
24.06.2020Renewal fee patent year 03
24.06.2020Renewal fee patent year 04
24.06.2020Renewal fee patent year 05
24.06.2020Renewal fee patent year 06
24.06.2020Renewal fee patent year 07
09.03.2021Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.03.2014
AL09.02.2022
AT09.02.2022
CY09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
MK09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
TR09.02.2022
IE13.03.2022
LU13.03.2022
BE31.03.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
[2024/29]
Former [2024/26]HU13.03.2014
AL09.02.2022
AT09.02.2022
CY09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
MK09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
IE13.03.2022
LU13.03.2022
BE31.03.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2024/23]AL09.02.2022
AT09.02.2022
CY09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
MK09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
IE13.03.2022
LU13.03.2022
BE31.03.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2024/20]AL09.02.2022
AT09.02.2022
CY09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
IE13.03.2022
LU13.03.2022
BE31.03.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/35]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
IE13.03.2022
LU13.03.2022
BE31.03.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/10]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
IE13.03.2022
LU13.03.2022
BE31.03.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/08]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SK09.02.2022
SM09.02.2022
IE13.03.2022
LU13.03.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/01]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/49]AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/48]AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/47]AT09.02.2022
DK09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/46]AT09.02.2022
DK09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/42]AT09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/39]AT09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
PT09.06.2022
Former [2022/36]AT09.02.2022
ES09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
PT09.06.2022
Former [2022/35]ES09.02.2022
HR09.02.2022
LT09.02.2022
NL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
PT09.06.2022
Former [2022/34]ES09.02.2022
LT09.02.2022
NL09.02.2022
NO09.05.2022
PT09.06.2022
Former [2022/33]LT09.02.2022
NO09.05.2022
Documents cited:Search[A]US2009162352  (ADLER MICHAEL [DE], et al);
 [A]WO2011029892  (HOFFMANN LA ROCHE [CH], et al);
 [A]WO2012013980  (JEZEK JAN [GB], et al)
by applicantWO15434299
 EP0003089
 USRE30985E
 EP0073657
 US4419446
 US4560655
 US4601978
 WO8700195
 US4657866
 US4675187
 US4676980
 US4767704
 US4816567
 DD266710
 WO8906692
 WO9003430
 US4927762
 US4965199
 WO9013646
 EP0404097
 WO9100360
 WO9110741
 WO9209690
 US5122469
 WO9301161
 WO9306213
 WO9308829
 WO9316185
 WO9404690
 WO9410202
 WO9411026
 WO9527062
 WO9607754
 US5500362
 US5545807
 US5545806
 WO9627011
 WO9630046
 US5569825
 WO9634096
 WO9633735
 US5571894
 US5587458
 US5625126
 US5633425
 US5641870
 US5648237
 US5661016
 US5736137
 WO9824893
 US5789199
 WO9845332
 US5840523
 US5869046
 US5959177
 US6040498
 US6054297
 US6075181
 US6150584
 US6235764
 US6248516
 EP0666868
 US6417429
 US6420548
 US6534524
 US6582959
 US6602684
 US2003190317
 US2003203409
 US2003206899
 US6703020
 WO2004035607
 WO2004056312
 WO2004065540
 WO2004113304
 US2005026229
 WO2005012359
 US6884879
 US2005100546
 WO2005044859
 US2005112126
 US6919436
 US2005176122
 US2005186208
 WO2005103081
 US2005260186
 US2005287149
 US6982321
 US2006009360
 US2006059575
 US2006104968
 US7060269
 US7078492
 US7087409
 US2006183887
 US7125978
 US2006258841
 US2006280747
 US7153507
 US2007020267
 US7189826
 WO2007031875
 US2007141065
 US7910098
 WO2011084750
 WO2020037392
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.